Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 20946667)

1.

Cellular and vaccine therapeutic approaches for gliomas.

Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA.

J Transl Med. 2010 Oct 14;8:100. doi: 10.1186/1479-5876-8-100. Review.

2.

Dendritic-cell- and peptide-based vaccination strategies for glioma.

Yamanaka R.

Neurosurg Rev. 2009 Jul;32(3):265-73; discussion 273. doi: 10.1007/s10143-009-0189-1. Epub 2009 Feb 13. Review.

PMID:
19214609
3.

Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.

Selznick LA, Shamji MF, Fecci P, Gromeier M, Friedman AH, Sampson J.

Neurosurg Rev. 2008 Apr;31(2):141-55; discussion 155. doi: 10.1007/s10143-008-0121-0. Epub 2008 Feb 8. Review.

4.

Dendritic cell therapy of high-grade gliomas.

Van Gool S, Maes W, Ardon H, Verschuere T, Van Cauter S, De Vleeschouwer S.

Brain Pathol. 2009 Oct;19(4):694-712. doi: 10.1111/j.1750-3639.2009.00316.x. Review.

PMID:
19744041
5.

Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.

Wang X, Zhao HY, Zhang FC, Sun Y, Xiong ZY, Jiang XB.

Cancer Invest. 2014 Nov;32(9):451-7. doi: 10.3109/07357907.2014.958234. Epub 2014 Sep 26. Review.

PMID:
25259676
6.

Peptide vaccine therapy for childhood gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Okada H.

Neurosurgery. 2013 Aug;60 Suppl 1:113-9. doi: 10.1227/01.neu.0000430769.33467.68. Review. No abstract available.

PMID:
23839362
7.

Dendritic cell immunotherapy for malignant gliomas.

Luptrawan A, Liu G, Yu JS.

Rev Recent Clin Trials. 2008 Jan;3(1):10-21. Review.

PMID:
18474011
8.

Peptide-based immunotherapeutic approaches to glioma: a review.

Yamanaka R, Itoh K.

Expert Opin Biol Ther. 2007 May;7(5):645-9. Review.

PMID:
17477802
9.

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

Akiyama Y, Oshita C, Kume A, Iizuka A, Miyata H, Komiyama M, Ashizawa T, Yagoto M, Abe Y, Mitsuya K, Watanabe R, Sugino T, Yamaguchi K, Nakasu Y.

BMC Cancer. 2012 Dec 27;12:623. doi: 10.1186/1471-2407-12-623.

10.

Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials.

van Gool S.

Immunotherapy. 2013 Oct;5(10):1043-6. doi: 10.2217/imt.13.86.

PMID:
24138559
11.

Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.

Mitra S, Li G, Harsh GR 4th.

Neurosurg Clin N Am. 2010 Jan;21(1):67-76. doi: 10.1016/j.nec.2009.08.010. Review.

PMID:
19944967
12.

Dendritic cell vaccines and immunity in glioma patients.

Wheeler CJ, Black KL.

Front Biosci. 2005 Sep 1;10:2861-81. Review.

PMID:
15970541
13.

Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.

Chiocca EA, Aguilar LK, Bell SD, Kaur B, Hardcastle J, Cavaliere R, McGregor J, Lo S, Ray-Chaudhuri A, Chakravarti A, Grecula J, Newton H, Harris KS, Grossman RG, Trask TW, Baskin DS, Monterroso C, Manzanera AG, Aguilar-Cordova E, New PZ.

J Clin Oncol. 2011 Sep 20;29(27):3611-9. doi: 10.1200/JCO.2011.35.5222. Epub 2011 Aug 15.

14.

Immunotherapy approaches for malignant glioma from 2007 to 2009.

Johnson LA, Sampson JH.

Curr Neurol Neurosci Rep. 2010 Jul;10(4):259-66. doi: 10.1007/s11910-010-0111-9. Review.

15.

[CTL precursor-oriented peptide vaccine therapy for malignant glioma].

Yajima N, Yamanaka R, Tanaka R, Shigemori M, Mine T, Itoh K.

Nihon Rinsho. 2005 Sep;63 Suppl 9:582-7. Review. Japanese. No abstract available.

PMID:
16201585
16.

Immunotherapy for malignant gliomas.

Bloch O.

Cancer Treat Res. 2015;163:143-58. doi: 10.1007/978-3-319-12048-5_9. Review.

PMID:
25468230
17.

Adoptive cell transfer therapy for malignant gliomas.

Ishikawa E, Takano S, Ohno T, Tsuboi K.

Adv Exp Med Biol. 2012;746:109-20. doi: 10.1007/978-1-4614-3146-6_9. Review.

PMID:
22639163
18.

[Peptide vaccination therapy for malignant glioma].

Yamanaka R, Itoh K.

Brain Nerve. 2007 Mar;59(3):251-61. Review. Japanese.

PMID:
17370651
19.

Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy.

Rodríguez PC, Rodríguez G, González G, Lage A.

MEDICC Rev. 2010 Winter;12(1):17-23. Review.

20.

Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.

Sonabend AM, Dana K, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S45-50. doi: 10.1586/14737140.7.12s.S45. Review.

PMID:
18076318
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk